← All Dror Ortho-design, INC filings

Dror Ortho-design, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
DROR
Dror Ortho-design, INC
10-K: Dror Ortho-Design Secures FDA Clearance for ZSmile Platform
Dror Ortho-Design, a development-stage company, announced FDA 510(k) clearance for its ZSmile orthodontic platform, despite ongoing operating losses and significant liquidity challenges.
OTC.Pink
DROR
Dror Ortho-design, INC
10-K: Dror Ortho-Design Reports Continued Losses in 2024, Focuses on ZSmile Platform Development
Dror Ortho-Design's 2024 annual report reveals ongoing losses as the company invests in its ZSmile platform, a novel approach to teeth alignment.
OTC.Pink
DROR
Dror Ortho-design, INC
10-K/A: Dror Ortho-Design Amends Annual Report to Correct Filing Errors and Include Additional Share Issuance Details
Dror Ortho-Design files an amendment to its annual report to correct a filing error regarding the registration of its common stock and to disclose an additional issuance of unregistered securities.
OTC.Pink
DROR
Dror Ortho-design, INC
10-K: Dror Ortho-Design Outlines Capital Structure and Growth Strategy in 10-K Filing
Dror Ortho-Design's 10-K filing details its capital structure, including common and preferred stock, warrants, and options, while outlining its innovative approach to the orthodontic market.